ESTRO 36 Abstract Book

Focus on lung cancer: What a radiotherapy department should offer their patients ..................... Abs. 385 How to write a research proposal for a grant? ....................................................................... Abs. 386 Symposium Rectal cancer – prediction and individualisation ...............................................................Abs. 387-389 Radiotherapy of brain tumours . ....................................................................................Abs. 390-392 MR guided radiotherapy: the new standard of care in 10 years time ...................................Abs. 393-396 Symposium with Proffered Papers Novel approaches in head and neck tumour control .........................................................Abs. 397-400 Symposium Experimental therapies ................................................................................................Abs. 401-403 Adaptive radiotherapy (both anatomical and ‘functional’ changes) ......................................Abs. 404-406 Focus on lung cancer: What a radiotherapy department should offer their patients ...............Abs. 407-409 Education and research grants ......................................................................................Abs. 410-414 Poster Viewing Session 9: Dosimetry ..................................................................................................Abs. 415-423 Proffered Papers Upper and Lower GI ....................................................................................................Abs. 424-429 Joint Symposium ESTRO-ESR: Radiomics and imaging databases for precision radiation oncology ...................Abs. 430-433 Symposium with Proffered Papers Novel approaches in prostate tumour control ..................................................................Abs. 434-436 Proffered Papers New technologies for imaging and therapy .....................................................................Abs. 437-442 Optimatisation algorithms for treatment planning ............................................................Abs. 443-448 Planning and quality assurance .....................................................................................Abs. 449-454 Poster Viewing Session 10: RTT .........................................................................................................Abs. 456-462 Award Lecture Donal Hollywood Award ..................................................................................................... Abs. 463 Proffered Papers Highlights of proffered papers . .....................................................................................Abs. 464-467 Symposium Non-rectal GI tumours: key open questions to be answered from (and for) the radiation oncologist! .................................................................................Abs. 469-471 Joint Symposium ESTRO-RANZCR: Big data to better radiotherapy .............................................................Abs. 472-475 Symposium Locally advanced breast cancer . ...................................................................................Abs. 476-478 Symposium with Proffered Papers Novel approaches in thoracic tumour treatment . .............................................................Abs. 479-482 Proffered Papers Inter-fraction motion management ................................................................................Abs. 483-491 Symposium Focus on prostate cancer: what is the best of radiotherapy we need to treat our patients with . ...............................................................................Abs. 492-494 Young ESTRO meets ESTRO School ...............................................................................Abs. 495-501 Poster Viewing Session 11: Head and neck and CNS .............................................................................Abs. 502-511 Proffered Papers CNS ..........................................................................................................................Abs. 512-517 Symposium Patient Reported Outcomes (PROs) in radiotherapy ..........................................................Abs. 518-520 Proffered Papers Oligometastatic disease ...............................................................................................Abs. 521-526 Symposium with Proffered Papers Novel approaches in colorectal tumour control ................................................................Abs. 527-529